NCT06974539Not yet recruiting
TULIP ReTrain Study
Optimization of PCaVision: A Prospective Study for CAD-based Detection of Clinically Significant Prostate Cancer Using mpUS and Contrast Agents
Source: ClinicalTrials.gov · Last updated 16 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This prospective clinical study aims to retrain and validate the PCaVision AI algorithm for the detection and localization of clinically significant prostate cancer (csPCa) using multiparametric ultrasound (mpUS) with two different ultrasound contrast agents: Sonovue and Optison. Data will be collected using a commercial version of the LOGIQ E10 ultrasound machine, with full histopathological correlation in patients undergoing radical prostatectomy.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 212 (estimated)
- First submitted
- 8 May 2025
- Start date
- Jul 2025
- Primary completion date
- Jul 2026
- Lead sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Diseases
- Prostate cancer
- NCT number
- NCT06974539
What you commit to
- Study type: Interventional
- Planned participants: 212
- From Jul 2025 to the primary completion date, Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe pulmonary hypertension
- Cardiac right-to-left shunt
- Known allergy to Sonovue or Optison
Other
- Contraindication for ultrasound contrast agents
Who the study is looking for
- Male ≥18 years
- Cohort 1: Histologically confirmed prostate cancer scheduled for radical prostatectomy
- Cohort 2: Negative multiparametric prostate MRI (PI-RADS ≤ 2)
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Amsterdam UMC Coordinator of this site? Confirm its status | Amsterdam | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.